Traumatic amputation of part of head

ST19_TRAUMAT_AMPUT_PART_HEAD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S08 Cause of death: ICD-10 — S08 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	60

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_HEAD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S0
Name in latin: Amputatio traumatica partis capitis

NAME	ST19_TRAUMAT_AMPUT_PART_HEAD
CONTROL_EXCLUDE	ST19_INJURI_HEAD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S08
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S08
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Traumatic amputation of part of head based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	19	41
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	48.55	41.95	51.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60: Matched controls
600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S08.1

ICD-10 Finland

Traumatic amputation of ear

+∞

43.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

9.2

17.3

S08.0

ICD-10 Finland

Avulsion of scalp

+∞

15.2

S06.0

ICD-10 Finland

Concussion

42.6

13.4

AA1AD

NOMESCO Finland

CT of head and brain

6.0

10.7

S01.3

ICD-10 Finland

Open wound of ear

+∞

9.6

S06.3

ICD-10 Finland

Focal brain injury

+∞

6.4

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

+∞

6.4

SPAT1254

SPAT

Administration of medicine

6.6

6.3

NA1AD

NOMESCO Finland

Cervical spine CT examination

10.9

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

3.56

4.21

1.7

2.0

1163.00

1050.51

nmol/l

0.21

(3023368) Bacteria identified in Blood by Culture

111

2.94

3.78

3.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

142

2.82

3.72

3.6

4.2

24.83

31.69

ng/l

0.42

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.94

3.55

3.7

3.8

27.27

477.49

ng/l

0.76

(3022217) INR in Platelet poor plasma by Coagulation assay

196

2.52

3.05

11.6

13.9

1.13

1.26

inr

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

146

2.54

3.04

1.8

1.9

90.72

90.87

pmol/l

0.00

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3.24

2.84

8.9

10.6

127.58

120.56

g/l

0.56

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.73

2.76

1.9

1.8

—

(3028300) Cannabinoids [Presence] in Urine

4.05

2.70

2.0

1.3

—

(3027944) Amphetamines [Presence] in Urine

4.05

2.70

2.0

1.3

—

(3016879) Cocaine [Presence] in Urine

4.05

2.70

2.0

1.3

—

(3027008) Opiates [Presence] in Urine

4.05

2.70

2.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

4.05

2.70

2.0

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4.23

2.56

2.1

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.73

2.51

1.4

1.6

—

(3022313) Gas panel - Capillary blood

4.25

2.33

4.1

2.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

121

2.29

2.28

2.8

2.3

657.23

306.41

u/l

0.34

111

(3023183) Ammonium ion [Moles/volume] in Plasma

5.94

2.26

2.8

6.3

33.00

29.67

umol/l

—

(3047181) Lactate [Moles/volume] in Blood

4.32

2.09

4.3

7.3

1.43

1.04

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

184

2.12

2.09

2.8

2.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.26

2.02

10.5

8.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

261

2.09

1.98

6.4

5.0

7.71

6.72

mmol/l

0.39

248

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.30

1.92

2.4

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.84

1.89

1.2

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.48

1.82

1.7

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

108

2.11

1.77

2.3

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.43

1.75

1.8

—

(3026008) Bacteria identified in Urine by Culture

118

2.04

1.69

3.8

2.7

—

(3019060) Gas panel - Arterial blood

2.69

1.50

3.1

5.4

—

(1761868) Lipid panel - Serum or Plasma

166

0.46

1.49

2.2

2.6

—

(3003694) ABO and Rh group [Type] in Blood

123

1.94

1.49

1.3

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.35

1.43

8.8

8.7

102.80

103.81

mmol/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.11

1.38

2.0

1.9

—

(3000991) Gas panel - Venous blood

2.41

1.30

9.3

9.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2.34

1.27

1.3

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

458

2.01

1.12

24.4

14.7

139.12

139.84

mmol/l

1.10

446

(3042936) Bacteria identified in Isolate by Culture

1.96

1.10

1.4

2.1

—

(3000850) Epithelial cells [#/volume] in Urine

1.84

1.10

2.3

2.0

2.57

4.95

e6/l

1.41

(3037467) Urinalysis macro (dipstick) panel - Urine

284

1.67

1.08

4.9

4.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

245

1.66

1.08

6.8

11.1

4.34

4.21

e9/l

0.13

211

(3033658) Prothrombin time (PT) actual/Normal

101

1.80

1.07

4.4

3.3

85.75

96.46

1.21

101

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.38

1.05

1.8

2.0

2.40

0.09

e6/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.13

1.04

1.1

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.94

1.02

1.2

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

146

1.67

1.01

3.7

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

192

1.63

0.99

4.3

7.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

461

1.96

0.99

24.5

14.7

3.98

3.96

mmol/l

0.16

449

(4200892) Spirometry reversibility

2.01

0.97

1.4

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.83

0.93

1.3

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.72

0.88

1.3

1.9

—

(3019225) pH of Specimen

2.04

0.87

3.7

2.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.97

0.84

13.7

10.2

1.32

1.88

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.77

0.82

1.8

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.78

0.79

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.28

0.78

16.4

13.5

24.60

24.47

mmol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

480

1.89

0.78

22.4

15.2

76.30

81.07

umol/l

1.08

480

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.65

0.73

1.8

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

167

1.50

0.71

3.3

2.7

136.45

131.90

ug/l

0.05

155

(3021440) Promyelocytes/100 leukocytes in Blood

1.93

0.70

4.8

4.3

—

0.09

—

(3025159) Blasts/100 leukocytes in Blood

1.93

0.70

4.8

4.0

—

0.73

—

(3002385) Erythrocyte distribution width [Ratio]

396

1.55

0.69

24.3

16.0

14.50

15.10

0.39

390

(3026782) Osmolality of Urine

1.65

0.69

2.3

2.1

621.08

550.28

mosm/kgh2o

0.55

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.86

0.68

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.86

0.68

14.2

13.1

95.38

92.96

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.79

0.65

4.8

3.8

—

1.23

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

350.95

—

(40761535) Cells panel - Urine sediment

1.79

0.60

2.3

3.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.79

0.60

4.0

3.5

7.12

146.74

ug/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.59

0.0

2.2

—

(3002256) Pathology report gross observation

1.48

0.48

1.4

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1.67

0.44

4.8

4.0

—

0.93

—

(3044889) 12 lead EKG panel

298

1.33

0.43

3.7

4.0

—

(4035726) Immunohistochemistry procedure

1.61

0.43

1.4

1.3

—

(3022621) pH of Urine by Test strip

1.61

0.43

2.2

1.9

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.42

0.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.40

0.0

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

514

1.50

0.36

27.5

19.1

134.83

139.57

g/l

1.94

506

(3024731) MCV [Entitic volume]

514

1.50

0.36

27.2

19.0

91.30

90.64

0.53

506

(3035941) MCH [Entitic mass]

514

1.50

0.36

27.3

18.9

30.41

30.29

0.21

506

(3037522) Nuclear Ab [Titer] in Serum

1.40

0.35

1.0

1.5

—

351.11

—

(3021601) Nitrite [Presence] in Urine by Test strip

215

1.28

0.35

4.3

4.5

0.00

estimate

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

491

1.44

0.32

12.1

9.6

24.71

28.86

u/l

1.04

475

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

408

1.29

0.32

5.4

5.3

40.52

40.26

mmol/mol

0.06

387

(3015736) pH of Urine

179

1.27

0.31

3.0

3.2

—

5.74

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.33

0.29

1.6

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

328

1.24

0.29

4.4

2.9

53.56

45.49

u/l

0.42

312

(3035350) Ketones [Presence] in Urine by Test strip

221

1.22

0.26

3.3

3.4

0.00

estimate

—

(36304419) Bacteria [Presence] in Urine

125

1.27

0.25

3.9

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

423

1.26

0.25

16.5

11.6

86.41

85.40

ml/min/173m2

0.12

345

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.27

0.23

3.4

10.1

—

(36660697) Celiac disease serology panel - Serum

1.27

0.23

1.0

1.3

—

(3000492) Spirometry study

1.24

0.22

1.4

—

(40758558) Short blood count panel - Blood

108

1.26

0.22

4.6

7.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

0.24

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.12

—

(40768800) Prostate Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(4034850) Laboratory test

0.00

0.20

0.0

12.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

158

1.20

0.19

4.2

4.0

20.16

20.37

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.23

0.19

1.7

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

120

0.80

0.18

4.7

3.7

0.00

estimate

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

429

1.20

0.17

4.2

4.3

5.81

5.94

mmol/l

0.30

397

(3019150) Specific gravity of Urine by Refractometry

102

1.22

0.16

3.3

3.5

—

1.02

—

(40761511) CBC panel - Blood by Automated count

471

1.22

0.16

17.3

11.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

309

1.15

0.15

3.2

3.3

—

(40768804) Tissue Pathology biopsy report

167

0.86

0.12

2.2

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.18

0.10

5.0

3.8

28.20

30.31

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.15

0.10

1.4

2.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

134

0.87

0.10

3.0

3.7

3.00

11.69

mg/mmol

—

(3022145) Colonoscopy Study observation

1.12

0.09

1.8

1.2

—

(3013512) EKG study

109

0.90

0.04

4.2

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

124

1.06

0.01

3.1

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

105

1.06

0.00

3.5

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

176

1.03

0.00

3.3

3.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(40768797) Stomach Pathology biopsy report

0.93

-0.00

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.3

—

6.70

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

12.2

—

885.00

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

3.2

—

5.54

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

129.17

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.0

—

92.57

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.94

-0.00

1.7

412.44

473.61

pmol/l

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(40768793) Breast Pathology biopsy report

0.00

-0.00

0.0

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.4

—

2.64

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

2.12

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.17

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

-0.00

0.0

2.0

—

3.14

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

107.80

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

9.44

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.70

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

12.88

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.3

—

3.23

—

(3045424) Erythrocytes [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

3.1

—

17.64

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.4

—

0.00

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

1.8

—

12.76

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

1.7

—

72.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

5.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.0

—

36.38

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

110

1.00

-0.00

1.6

1.2

9.57

1.17

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.8

—

1572.67

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

-0.00

0.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

2.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

(3024928) Oxygen saturation in Venous blood

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TRAUMAT_AMPUT_PART_HEAD – Traumatic amputation of part of head

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Traumatic amputation of part of head

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Traumatic amputation of part of head (ST19_TRAUMAT_AMPUT_PART_HEAD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints